🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

162 results for “Fondazione” Clear

  1. Zimberelimab, Trodelvy 200 mg powder for concentrate for solution for infusion

    Fondazione Telethon ETS

    Muscle-Invasive Bladder cancer

    phase 2 small molecule active

    1 trial

  2. A Multicentre, Randomised Phase Ib Trial to evaluate Neoadjuvant Immunotherapy Combination of Nivolumab alone or plus Ipilimumab with the IL-2 Superkine MDNA11 alone or with Tocilizumab in Patients with High-Risk, Surgically Resectable Melanoma – NEO-CYT

    Fondazione Telethon ETS

    High-Risk, Surgically Resectable Melanoma

    phase 1 other active

    1 trial

  3. A phase I trial of IMA970A plus Montanide in combination with Durvalumab (anti-PD-L1) in patients with very early, early and intermediate stage of hepatocellular carcinoma after any standard treatments.

    Fondazione Telethon ETS

    Hepatocellular carcinoma

    phase 1 other active

    1 trial

  4. Single microdose trial - CXCR4 PET tracer - Pharmacokinetics and pharmacodynamics of [68Ga]Ga-R54, a CXCR4-targeted radiopharmaceutical in patients with advanced solid tumors.

    Fondazione Telethon ETS

    Advanced solid neoplasm (breast, lung, colon, ovary, pancreas) characterized by positive CXCR4 expression by immunohistochemistry

    phase 1 other active

    1 trial

  5. ACETYLSALICYLIC ACID, ACETYLSALICYLIC ACID, CLOPIDOGREL, CLOPIDOGREL

    Fondazione Telethon ETS

    Patients with Stable or Unstable coronary syndromes who have undergone successful PCI

    approved small molecule active

    1 trial

  6. Amiodarone Hikma 50 mg/ml soluzione iniettabile, BUPISEN 5 mg/ml soluzione iniettabile, Lidocaina Kabi 20 mg/ml soluzione iniettabile

    Fondazione Telethon ETS

    electrical storm

    approved small molecule active

    1 trial

  7. COLECALCIFEROL , The Placebo product consists only of pure Ph. Eur. refined olive and it differs from Test product for the absence of active substance only: therefore, there are no reasons to suspect that the placebo product will undergo changes in its physical characteristics or degradation., Placebo

    Fondazione Telethon ETS

    obese elderly people with vitamin D deficiency

    approved small molecule active

    1 trial

  8. ENZALUTAMIDE, DOCETAXEL, ABIRATERONE

    Fondazione Telethon ETS

    metastatic castration resistant prostate cancer without mutations of BRCA1/2 genes or unknown

    approved small molecule active

    1 trial

  9. ESOMEPRAZOLE, ESOMEPRAZOLE

    Fondazione Telethon ETS

    obesity

    approved small molecule active

    1 trial

  10. Enbrel 25 mg powder and solvent for solution for injection, ADALIMUMAB, ETANERCEPT, Humira 20 mg solution for injection in pre-filled syringe

    Fondazione Telethon ETS

    Juvenile Idiopathic Arthritis

    approved small molecule active

    1 trial

  11. GEMCITABINE HYDROCHLORIDE, CISPLATIN, AVELUMAB, CISPLATIN, CISPLATIN, CISPLATIN, CARBOPLATIN, CARBOPLATIN, GEMCITABINE HYDROCHLORIDE

    Fondazione Telethon ETS

    metastatic or locally advanced urothelial cancer

    approved small molecule active

    1 trial

  12. Glivec 100 mg hard capsules, Tasigna 150 mg hard capsules

    Fondazione Telethon ETS

    Chronic Myeloid Leukemia (CML) in Chronic Phase (CP)

    approved small molecule active

    1 trial

  13. LENVATINIB, NIVOLUMAB, CABOZANTINIB, LENVATINIB, NIVOLUMAB, AXITINIB, CABOZANTINIB, PEMBROLIZUMAB, IPILIMUMAB, AXITINIB, AXITINIB

    Fondazione Telethon ETS

    metastatic or locally advanced renal cell carcinoma

    approved small molecule active

    1 trial

  14. Plavix 75 mg film-coated tablets, CARDIOASPIRIN 100 mg Compresse gastroresistenti, CARDIOASPIRIN 100 mg Compresse gastroresistenti, Plavix 300 mg film-coated tablets

    Fondazione Telethon ETS

    Patients with atrial fibrillation undergoing percutaneous left atrial appendage closure with the Amulet device

    approved small molecule active

    1 trial

  15. SEMAGLUTIDE, SEMAGLUTIDE, INSULIN GLARGINE, DAPAGLIFLOZIN

    Fondazione Telethon ETS

    type 2 diabetes

    approved small molecule active

    1 trial

  16. Same form and composition of the drug, except for the active ingredient., BRONCHO VAXOM Adulti 7 mg capsule rigide

    Fondazione Telethon ETS

    Elderly patients with a positive history of at least two respiratory system infections in the year preceding enrollment and residents for at least 6 months in a Healthcare Residence.

    approved small molecule active

    1 trial

  17. TAGRISSO 80 mg film-coated tablets

    Fondazione Telethon ETS

    Patients with EGFR mutant NSCLC according to TP53 mutational status

    approved small molecule active

    1 trial

  18. WARFARIN, LYSINE ASPIRIN, CLOPIDOGREL, ACETYLSALICYLIC ACID, ATORVASTATIN, DILTIAZEM, BISOPROLOL, ACETYLCHOLINE CHLORIDE, GLYCERYL TRINITRATE, RAMIPRIL

    Fondazione Telethon ETS

    Myocardial infarction with non-obstructive coronary arteries (MINOCA)

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources